Close Menu

NEW YORK – Bruker reported after the close of the market Monday that revenues in the third quarter fell 2 percent year over year.

For the three months ended Sept. 30, revenues decreased to $511.4 million from $521.1million in Q3 2019, beating the consensus Wall Street estimate of $483.7 million.

The company saw a 2 percent positive effect on revenues from currency translation and a positive effect of less than 1 percent from acquisitions.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

In Nucleic Acids Research this week: pan-cancer atlas focus on miRNA biogenesis mutations , methylation analysis of pig skeletal muscles, and more.

President-elect Joe Biden has nominated Eric Lander to serve as director of the Office of Science and Technology Policy, the Associated Press says.

Nature News writes that scientists are trying to figure out how to name the new strains of SARS-CoV-2 that are emerging.

The New York Times reports that researchers are studying identical twins who had COVID-19 to understand the influence of genetics on disease severity.